Schedule 13D ownership disclosure

PRANA BIOTECHNOLOGY LTD SHS (A

Security class unavailable · CUSIP: Q7739U108

Event date: 2022-03-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
261,703,353
Percent of class
10.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-030696
Form type
SC 13D/A
Filer
ALTERITY THERAPEUTICS LTD
CIK
CIK 1131343
Filed
Mar 04, 2022
Reporting period
Mar 02, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub